New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
11:02 EDTDVA, SKH, HCA, LH, KND, THC, LPNT, DGX, FMS, ADK, UHS, CYHDoc fix draft positive for labs, hospitals, skilled nursing, says Wells Fargo
Wells Fargo views the draft copy of the SGR ''Doc Fix'' bill released by the House of Representatives this morning as positive for labs, dialysis providers, hospitals and skilled nursing facility operators. The firm added that it thinks the chances the bill passes are high. Quest Diagnostics (DGX) and LabCorp (LH) are publicly traded labs, while DaVita (DVA) and Fresenius Medical (FMS) operate dialysis centers. Publicly traded hospital operators include Community Health (CYH), HCA Holdings (HCA), LifePoint Hospitals (LPNT), Tenet (THC) and Universal Health (UHS). Skilled nursing stocks include Skilled Healthcare (SKH), AdCare (ADK) and Kindred Healthcare (KND).
News For DGX;LH;CYH;LPNT;HCA;UHS;THC;SKH;ADK;KND;DVA;FMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
07:08 EDTDGXQuest Diagnostics backs FY15 adjusted EPS view $4.70-$4.85, consensus $4.78
Subscribe for More Information
07:06 EDTDGXQuest Diagnostics reports Q1 adjusted EPS $1.05, consensus $1.04
Subscribe for More Information
April 22, 2015
15:50 EDTDGXNotable companies reporting before tomorrow's open
Subscribe for More Information
07:07 EDTFMSEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
April 21, 2015
08:14 EDTLH, DGXQuest Diagnostics and Inserm launch BRCA Share initiative
Quest Diagnostics (DGX) and Inserm, the French National Institute of Health and Medical Research institution, launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data. The program's goal is to accelerate research on BRCA gene mutations, particularly variants of uncertain significance, to improve the ability of clinical laboratory diagnostics to predict which individuals are at risk of developing hereditary breast and ovarian cancers. Laboratory Corporation of America Holdings (LH) is the first participant in the initiative, which is structured as a user group. B
06:40 EDTDGX, LHStart-up to offer saliva test for breast cancer susceptibility, NY Times says
Subscribe for More Information
April 20, 2015
12:40 EDTHCAHCA Holdings to repurchase 3.8M shares
Subscribe for More Information
April 17, 2015
16:11 EDTADKAdCare announces resignation of Chief Accounting Officer Sheryl Wolf
On April 14, Sheryl Wolf, the Senior Vice President, Controller and Chief Accounting Officer of AdCare Health Systems, resigned from the company effective May 1. After Wolf's departure, Allan Rimland, the company’s President and CFO, will serve as the company’s principal accounting officer.
April 16, 2015
08:28 EDTHCAHCA Holdings reported strong Q1 results, says RBC Capital
After HCA Holdings reported stronger than expected Q1 results, RBC Capital says it was particularly encouraged that the company raised its guidance by more than the amount by which its earnings beat guidance. The firm says this indicates that the company has strong confidence in the sustainability of its underlying trends. RBC keeps an Outperform rating on the shares.
07:28 EDTHCAHCA Holdings results impressive, says SunTrust
Subscribe for More Information
April 15, 2015
12:32 EDTDGXFocus Diagnostics announced FDA clearance for Simplexa Group A Strep Direct Kit
Subscribe for More Information
10:01 EDTDVADaVita sees taking $250M reserve for Vanier litigation
In a regulatory filing yesterday related to a bond offering, DaVita noted it has received subpoenas or other requests for documents from the federal government in connection with the Vainer private civil suit, the Swoben private civil suit, the 2011 U.S. Attorney Medicaid investigation, the 2015 U.S. Attorney Transportation Investigation and the JSA investigation. In each of the Vainer and Swoben private civil suits, a relator filed a complaint against the company in federal court under the qui tam provisions of the False Claims Act and pursued the claims independently after the government declined to intervene. With regard to the Vanier private civil suit, the parties are engaged in active litigation. The parties in that suit completed discovery in early 2014; however, in August 2014, the court granted relators’ motion for sanctions and reopened discovery on a limited basis. The court in Vainer is considering the plaintiffs’ request for further sanctions, which could result in a range of outcomes from no other sanctions to plaintiffs’ request to strike our answer. Certain of these sanctions could materially adversely impact the company's ability to defend the case, DaVita said. "While we cannot predict the ultimate outcome of this case, if the case is resolved in favor of the plaintiffs, its resolution could have a material adverse effect on our earnings and cash flows. We recently commenced settlement discussions with the plaintiffs in Vainer." The company said it expects to accrue an estimated loss contingency reserve of $250M related to this matter. "Negotiations are ongoing and we can make no assurances as to whether the Vainer suit will settle and, if it does settle, whether it will settle for an amount higher than the current reserve," DaVita added. With regard to the Swoben private civil suit, in July 2013, the court granted HCP’s motion and dismissed with prejudice all of the claims in the Third Amended Complaint, and in October 2013 the plaintiff filed an appeal of the dismissal, which is currently pending.
09:54 EDTKNDWells positive on HealthSouth, Kindred after ''doc fix'' bill
Subscribe for More Information
08:40 EDTTHC, LPNT, HCA, UHS, CYHHospital stocks rise in pre-market after HCA boosts 2015 guidance
Subscribe for More Information
08:34 EDTHCAHCA Holdings says Q1 same facility admissions increased 5.1%
Subscribe for More Information
08:33 EDTHCAHCA Holdings raises FY15 adjusted EPS view to $4.90-$5.30 from $4.55-$4.95
Consensus is $4.93. Raises FY15 revenue view to $39B-$40B from $38.5B-$39.5B. Raises FY adjusted EBITDA view to $7.55B-$7.85B from $7.35B-$7.65B. Still sees FY CapEx approx. $2.4B. The Company’s revised 2015 guidance contains a number of assumptions that remain unchanged from its February 2015 guidance, including: The Company estimates approximately 6 to 7 percent of Adjusted EBITDA is attributable to the Patient Protection and Affordable Care Act.
08:31 EDTHCAHCA Holdings sees Q1 EPS approx. $1.35, conseuss $1.14
Subscribe for More Information
07:41 EDTFMSEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
12:13 EDTDVADaVita announces $725.94M repurchase program
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use